Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
8 studies found for:    SPC3649
Show Display Options
Rank Status Study
1 Completed SPC3649 Multiple Dose Study in Healthy Volunteers
Condition: Hepatitis C
Interventions: Drug: SPC3649;   Drug: saline
2 Completed Safety Study of SPC3649 in Healthy Men
Condition: Hepatitis C
Intervention: Drug: SPC3649
3 Completed Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects
Condition: Hepatitis C
Interventions: Drug: miravirsen;   Drug: saline
4 Unknown  Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Miravirsen sodium
5 Unknown  Long-term Extension to Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Miravirsen
6 Completed Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects
Conditions: Hepatitis C;   Chronic Hepatitis C
Interventions: Drug: Miravirsen sodium;   Drug: Telaprevir
7 Active, not recruiting Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin
Condition: Chronic Hepatitis C
Intervention:
8 Unknown  Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Miravirsen;   Drug: Telaprevir;   Drug: Ribavirin

Study has passed its completion date and status has not been verified in more than two years.